<DOC>
	<DOCNO>NCT00588640</DOCNO>
	<brief_summary>The purpose study determine safe dose d-methadone give , without cause severe side effect patient chronic pain . Patients ask participate Phase I portion study .</brief_summary>
	<brief_title>Study D-Methadone Patients With Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<mesh_term>Otorhinolaryngologic Neoplasms</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Phase I Phase II portion study : 18 year age old Chronic pain average 24 hour intensity rat least 3 verbal numerical scale 010 24 hour prior study entry . Give informed consent participate study . Karnofsky Performance Score ( KPS ) &gt; = 80 Negative urine pregnancy test , verify study nurse , study entry ( woman childbearing potential ) . Patients must also use medically approve contraceptive method study period . Phase I : Responsible companion live patient study . Phase II : Group 1 Patients must take chronic opioid therapy ( long act morphine , long act oxycodone , transdermal fentanyl ) stable dose minimum four day . The dose need short act opioid need stable . Group 2 Patients must receive opioids must cancer relate neuropathic pain secondary postchemotherapy peripheral neuropathy , postradiation and/or post surgical plexopathy , radiculopathy neuropathy , post herpetic neuralgia . Phase I Phase II : Known hypersensitivity methadone Patient take methadone history methadone treatment within one month study enrollment . Patient require change dose one follow medication within 2 week study enrollment : Abacavir , Benzodiazepines , Carbamazepine , Efavirenz , Fluconazole , Fluvoxamine , FOS amprenavir , Fosphenytoin , Naltrexone , Nelfinavir , Nevirapine , Phenytoin , Rifampin , Rifapentine , Risperidone , Ritonavir , St. John 's Wort , Zidovudine Hepatic function test ( SGOT , alkaline phosphatase , bilirubin ) great 2 time upper limit normal creatinine great 1.4 within 30 day study entry . Neurologic psychiatric disease sufficient , investigator 's opinion , compromise data collection . Women pregnant nursing . Women childbearing potential agree use medically recognize method contraception study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>HEENT cancer</keyword>
</DOC>